|
|
| Product Name: |
Fulvestrant |
| Synonyms: |
(7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol; (7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol; (17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol; Faslodex |
| CAS RN.: |
129453-61-8 |
| Appearance: |
white powder |
| Molecular Weight: |
606.7708 |
| Molecular Formula: |
C32H47F5O3S |
| Density: |
1.201g/cm3 |
| Boiling Point(℃): |
674.8°C at 760 mmHg |
| Flash Point(℃): |
361.9°C |
| refractive_index: |
1.521 |
Usage:Fulvestrant is a type of hormone treatment. It is also called Faslodex. It is a treatment for post menopausal women with advanced breast cancer.A novel steroidal estrogen antagonist reported to lack any partial agonist activity. Also used as an antineoplastic raw materials.
Company Profile
|
|
